Journal of Crohn's and Colitis, 2021
TREM-1+ Macrophages Define a Pathogenic Cell Subset in the Intestine of Crohn’s Disease Patients

Caër C., Gorreja F., Forsskåhl S. et al.

The American Journal of Cardiology, 2021
Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study)

Hussain A., Tang O., Sun C. et al.

Journal of Allergy and Clinical Immunology, 2021
Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council

Renert-Yuval Y., Thyssen J., Bissonnette R. et al.

The Journal of Infectious Diseases, 2021
Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C

Khera T., Du Y., Todt D. et al.

ERJ Open Research, 2021
Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases: an explorative study

Majewski S., Zhou X., Miłkowska-Dymanowska J. et al.

Journal of Clinical Investigation, 2021
Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity

Falck-Jones S., Vangeti S., Yu M. et al.

Proceedings of the National Academy of Sciences, 2021
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity

Kvedaraite E., Hertwig L., Sinha I. et al.

Scientific Reports, 2021
Accelerated inflammatory aging in Alzheimer’s disease and its relation to amyloid, tau, and cognition

Cullen N., Mälarstig A., Stomrud E. et al.

Scientific Reports, 2021
Blood-based protein profiling identifies serum protein c-KIT as a novel biomarker for hypertrophic cardiomyopathy

Sonnenschein K., Fiedler J., de Gonzalo-Calvo D. et al.

Scientific Reports, 2021
Differential effects on blood and cerebrospinal fluid immune protein markers and kynurenine pathway metabolites from aerobic physical exercise in healthy subjects

Isung J., Granqvist M., Trepci A. et al.

Cancer Cell, 2021
Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients

Remsik J., Wilcox J., Babady N. et al.

Clinical Infectious Diseases, 2021
Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease

Stanley T., Fourman L., Wong L. et al.

PLOS Medicine, 2021
Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study

Wallentin L., Eriksson N., Olszowka M. et al.

Scientific Reports, 2021
Role of PAI-1 in hepatic steatosis and dyslipidemia

Levine J., Oleaga C., Eren M. et al.

ESC Heart Failure, 2021
Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension

Arvidsson M., Ahmed A., Bouzina H. et al.

Metabolites, 2020
Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)

Chorell E., Olsson T., Jansson J. et al.

Journal of Autoimmunity, 2020
Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis

Buitrago-Molina L., Pietrek J., Noyan F. et al.

Journal of Fungi, 2020
Polymorphisms within the TNFSF4 and MAPKAPK2 Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics Consortium

Sánchez-Maldonado J., Moñiz-Díez A., ter Horst R. et al.

United European Gastroenterology Journal, 2020
Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients

Owusu Sekyere S., Port K., Deterding K. et al.

European Journal of Heart Failure, 2020
Is acute heart failure a distinctive disorder? An analysis from BIOSTAT‐CHF

Davison B., Senger S., Sama I. et al.